During the past decade, Universitätsklinikum Ulm; Klinik für Urologie conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universitätsklinikum Ulm; Klinik für Urologie" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator, "Chugai" with 1 trials as a collaborator and "Exelixis" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Universitätsklinikum Ulm; Klinik für Urologie" are "Bladder Cancer" (1 trials), "Carcinoma, Renal Cell" (1 trials), "Carcinoma, Transitional Cell" (1 trials), "Muscle-invasive Bladder Cancer" (1 trials) and "Urinary Bladder Cancer" (1 trials). Many other conditions were trialed in "Universitätsklinikum Ulm; Klinik für Urologie" in a lesser frequency.

Most popular intervention types in "Universitätsklinikum Ulm; Klinik für Urologie" are "Drug" (6 trials), "Other" (1 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (4 trials), "Atezolizumab (MPDL3280A) [TECENTRIQ], an engineered anti-PDL1 antibody" (1 trials), "Cabozantinib" (1 trials), "Docetaxel" (1 trials) and "Nivolumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universitätsklinikum Ulm; Klinik für Urologie" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Universitätsklinikum Ulm; Klinik für Urologie". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Universitätsklinikum Ulm; Klinik für Urologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Universitätsklinikum Ulm; Klinik für Urologie, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".